Insufficient scRNA-seq data for expression of TRIM7 at single-cell level.
Insufficient scRNA-seq data for expression of TRIM7 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 97% | 927.54 | 632 / 653 | 84% | 3.55 | 508 / 605 |
esophagus | 66% | 1240.65 | 956 / 1445 | 84% | 6.95 | 153 / 183 |
pancreas | 43% | 244.87 | 140 / 328 | 78% | 3.58 | 138 / 178 |
skin | 86% | 2630.34 | 1552 / 1809 | 34% | 0.82 | 160 / 472 |
lung | 58% | 321.44 | 335 / 578 | 49% | 2.52 | 569 / 1155 |
bladder | 48% | 233.19 | 10 / 21 | 59% | 3.24 | 296 / 504 |
uterus | 29% | 167.49 | 49 / 170 | 72% | 5.33 | 329 / 459 |
muscle | 100% | 4944.15 | 803 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 7.89 | 45 / 45 |
prostate | 60% | 364.77 | 148 / 245 | 30% | 0.47 | 151 / 502 |
heart | 81% | 598.68 | 697 / 861 | 0% | 0 | 0 / 0 |
adrenal gland | 13% | 55.47 | 34 / 258 | 57% | 1.72 | 130 / 230 |
intestine | 19% | 91.11 | 188 / 966 | 50% | 3.06 | 263 / 527 |
kidney | 30% | 168.46 | 27 / 89 | 36% | 0.97 | 327 / 901 |
blood vessel | 65% | 387.49 | 870 / 1335 | 0% | 0 | 0 / 0 |
stomach | 11% | 57.85 | 41 / 359 | 43% | 1.65 | 122 / 286 |
brain | 33% | 989.89 | 872 / 2642 | 19% | 0.42 | 137 / 705 |
breast | 36% | 165.90 | 164 / 459 | 13% | 0.34 | 149 / 1118 |
adipose | 26% | 126.27 | 312 / 1204 | 0% | 0 | 0 / 0 |
ovary | 14% | 76.96 | 26 / 180 | 3% | 0.05 | 15 / 430 |
peripheral blood | 15% | 78.89 | 136 / 929 | 0% | 0 | 0 / 0 |
spleen | 12% | 53.14 | 29 / 241 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 10% | 0.23 | 41 / 406 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.06 | 1 / 29 |
eye | 0% | 0 | 0 / 0 | 3% | 0.03 | 2 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0016567 | Biological process | protein ubiquitination |
GO_0140374 | Biological process | antiviral innate immune response |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0005515 | Molecular function | protein binding |
GO_0008270 | Molecular function | zinc ion binding |
Gene name | TRIM7 |
Protein name | E3 ubiquitin-protein ligase TRIM7 (EC 2.3.2.27) (Glycogenin-interacting protein) (RING finger protein 90) (Tripartite motif-containing protein 7) |
Synonyms | GNIP RNF90 |
Description | FUNCTION: E3 ubiquitin-protein ligase that have both tumor-promoting and tumor-suppressing activities and functions in several biological processes including innate immunity, regulation of ferroptosis as well as cell proliferation and migration . Acts as an antiviral effector against multiple viruses by targeting specific viral proteins for ubiquitination and degradation including norovirus NTPase protein or SARS-CoV-2 NSP5 and NSP8 proteins . Mechanistically, recognizes the C-terminal glutamine-containing motif usually generated by viral proteases that process the polyproteins and trigger their ubiquitination and subsequent degradation . Mediates 'Lys-63'-linked polyubiquitination and stabilization of the JUN coactivator RNF187 in response to growth factor signaling via the MEK/ERK pathway, thereby regulating JUN transactivation and cellular proliferation . Promotes the TLR4-mediated signaling activation through its E3 ligase domain leading to production of pro-inflammatory cytokines and type I interferon (By similarity). Also plays a negative role in the regulation of exogenous cytosolic DNA virus-triggered immune response. Mechanistically, enhances the 'Lys-48'-linked ubiquitination of STING1 leading to its proteasome-dependent degradation . Mediates the ubiquitination of the SIN3-HDAC chromatin remodeling complex component BRMS1 . Modulates NCOA4-mediated ferritinophagy and ferroptosis in glioblastoma cells by ubiquitinating NCOA4, leading to its degradation . .; FUNCTION: (Microbial infection) Promotes Zika virus replication by mediating envelope protein E ubiquitination. . |
Accessions | ENST00000274773.12 [Q9C029-2] ENST00000422067.2 [Q9C029-3] Q9C029 ENST00000393315.5 [Q9C029-3] ENST00000393319.7 [Q9C029-4] ENST00000334421.5 [Q9C029-1] |